BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005;15:371-378. [PMID: 16202051 DOI: 10.1111/j.1365-3148.2005.00610.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015; 7(3): 600-606 [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
2 Jose-Abrego A, Panduro A, Fierro NA, Roman S. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status. J Med Virol 2017;89:2149-57. [PMID: 28792071 DOI: 10.1002/jmv.24913] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
3 González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010;50:221-30. [PMID: 19682332 DOI: 10.1111/j.1537-2995.2009.02343.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
4 Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010;155:149-58. [PMID: 20091193 DOI: 10.1007/s00705-009-0559-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
5 Dehesa-Violante M, Nuñez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007;38:606-11. [PMID: 17613351 DOI: 10.1016/j.arcmed.2007.03.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
6 Elghannam DM, Aly RM, Goda EF, Eltoraby EE, Farag RE. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci 2009;3:14-7. [PMID: 20041091 DOI: 10.4103/0973-6247.45256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kang SY, Kim MH, Lee WI. The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol. 2010;82:1508-1514. [PMID: 20648604 DOI: 10.1002/jmv.21862] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
8 Zeiler T, Karger R, Slonka J, Ketschmer V, Radsak K. Introduction of anti-HBc testing of blood donors in Germany. Transfus Med 2006;16:441-3. [DOI: 10.1111/j.1365-3148.2006.00685.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Mhalla S, Hammoud R, Frih A, Kadri Y, El Argoubi A, Elmay M, Mastouri M. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia. Med Mal Infect 2018;48:175-9. [PMID: 29249466 DOI: 10.1016/j.medmal.2017.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Fernández-Galindo DA, Galván-Ramírez ML, Andrade-Sierra J, González-Espinoza E, Evangelista-Carrillo LA, Mendoza-Cabrera S, Rodríguez-Pérez LR, Chiquete E, Armendáriz-Borunda J, Sánchez-Orozco LV. Occult hepatitis B in kidney transplants recipients and donors from Western Mexico. Int J Infect Dis 2020;91:17-21. [PMID: 31669141 DOI: 10.1016/j.ijid.2019.10.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wu T, Kwok RM, Tran TT. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues. Am J Gastroenterol 2017;112:1780-8. [PMID: 29087395 DOI: 10.1038/ajg.2017.397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
12 Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis 2010;14:e308-10. [PMID: 19656713 DOI: 10.1016/j.ijid.2009.05.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
13 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
14 El-Ghitany EM, Farghaly AG. Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity. J Virol Methods. 2013;194:190-193. [PMID: 24004823 DOI: 10.1016/j.jviromet.2013.08.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Muselmani W, Habbal W, Monem F. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Transfus Med 2013;23:265-8. [PMID: 23621787 DOI: 10.1111/tme.12043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 El Ekiaby M, Lelie N, Allain J. Nucleic acid testing (NAT) in high prevalence–low resource settings. Biologicals 2010;38:59-64. [DOI: 10.1016/j.biologicals.2009.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
17 Morales-Romero J, Vargas G, García-Román R. Occult HBV infection: a faceless enemy in liver cancer development. Viruses. 2014;6:1590-1611. [PMID: 24717680 DOI: 10.3390/v6041590] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
18 Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon. 2011;11:714-718. [PMID: 22235213 DOI: 10.5812/kowsar.1735143x.694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
19 Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-Transfusion Occult Hepatitis B (OBI): A Global Challenge for Blood Recipients and Health Authorities. Hepat Mon 2011;11:714-8. [DOI: 10.5812/kowsar.1735143x.505] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
20 María García-montalvo B, Patricia Ventura-zapata L. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Annals of Hepatology 2011;10:133-41. [DOI: 10.1016/s1665-2681(19)31561-3] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Torres-baranda R, Bastidas-ramírez BE, Maldonado-gonzález M, Sánchez-orozco LV, Vázquez-vals E, Rodríguez-noriega E, Panduro A. Occult hepatitis B in mexican patients with HIV, an analysis using nested polymerase chain reaction. Annals of Hepatology 2006;5:34-40. [DOI: 10.1016/s1665-2681(19)32037-x] [Cited by in Crossref: 17] [Article Influence: 1.1] [Reference Citation Analysis]
22 Sosa-Jurado F, Hilda Rosas-Murrieta N, Guzman-Flores B, Perez Zempoaltecalt C, Patricia Sanchez Torres A, Ramirez Rosete L, Bernal-Soto M, Marquez-Dominguez L, Melendez-Mena D, Angel Mendoza Torres M, Teresa Lopez Delgado M, Reyes-Leyva J, Vallejo-Ruiz V, Santos-Lopez G. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA. Hepat Mon 2016;16:e36942. [PMID: 27630726 DOI: 10.5812/hepatmon.36942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]